ZA814203B - Protection of lyophilized betalactams from color formation - Google Patents

Protection of lyophilized betalactams from color formation

Info

Publication number
ZA814203B
ZA814203B ZA814203A ZA814203A ZA814203B ZA 814203 B ZA814203 B ZA 814203B ZA 814203 A ZA814203 A ZA 814203A ZA 814203 A ZA814203 A ZA 814203A ZA 814203 B ZA814203 B ZA 814203B
Authority
ZA
South Africa
Prior art keywords
betalactams
lyophilized
protection
color formation
color
Prior art date
Application number
ZA814203A
Other languages
English (en)
Inventor
Eizo Hirai
Kazuhiro Shima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of ZA814203B publication Critical patent/ZA814203B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
ZA814203A 1980-06-23 1981-06-22 Protection of lyophilized betalactams from color formation ZA814203B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (1)

Publication Number Publication Date
ZA814203B true ZA814203B (en) 1982-09-29

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA814203A ZA814203B (en) 1980-06-23 1981-06-22 Protection of lyophilized betalactams from color formation

Country Status (31)

Country Link
US (1) US4418058A (nl)
JP (1) JPS5711909A (nl)
KR (1) KR840000693B1 (nl)
AR (1) AR230007A1 (nl)
AT (1) AT380790B (nl)
AU (1) AU541627B2 (nl)
BE (1) BE889351A (nl)
BG (1) BG37991A3 (nl)
CA (1) CA1164801A (nl)
CH (1) CH648210A5 (nl)
CS (1) CS221835B2 (nl)
DD (1) DD159879A5 (nl)
DE (1) DE3124592A1 (nl)
DK (1) DK158443C (nl)
ES (1) ES503283A0 (nl)
FI (1) FI75490C (nl)
FR (1) FR2484835A1 (nl)
GB (1) GB2078737B (nl)
GR (1) GR75646B (nl)
HU (1) HU183494B (nl)
IE (1) IE51331B1 (nl)
IL (1) IL63136A (nl)
IT (1) IT1144812B (nl)
NL (1) NL191777C (nl)
NO (1) NO156036C (nl)
NZ (1) NZ197414A (nl)
PT (1) PT73239B (nl)
RO (1) RO82720B (nl)
SE (1) SE460702B (nl)
YU (1) YU44416B (nl)
ZA (1) ZA814203B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
BR0112417A (pt) * 2000-07-13 2003-07-01 Daiichi Seiyaku Co Composições farmacêuticas contendo composto dds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (nl) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
FR2374031A1 (fr) * 1976-12-17 1978-07-13 Scherico Ltd Nouvelles formulations d'antibiotiques b-lactame, leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
RO82720A (ro) 1984-05-23
SE460702B (sv) 1989-11-13
DK274981A (da) 1981-12-24
NO156036C (no) 1987-07-15
BE889351A (fr) 1981-10-16
ES8203887A1 (es) 1982-04-01
YU44416B (en) 1990-08-31
SE8103904L (sv) 1981-12-24
IT8167863A0 (it) 1981-06-22
YU157381A (en) 1984-10-31
KR830005848A (ko) 1983-09-14
JPS6364405B2 (nl) 1988-12-12
GR75646B (nl) 1984-08-02
CS221835B2 (en) 1983-04-29
DE3124592C2 (nl) 1990-12-20
DD159879A5 (de) 1983-04-13
ES503283A0 (es) 1982-04-01
US4418058A (en) 1983-11-29
IL63136A (en) 1984-07-31
NL191777B (nl) 1996-04-01
FI75490B (fi) 1988-03-31
JPS5711909A (en) 1982-01-21
CH648210A5 (de) 1985-03-15
CA1164801A (en) 1984-04-03
PT73239A (en) 1981-07-01
AR230007A1 (es) 1984-02-29
GB2078737A (en) 1982-01-13
FR2484835B1 (nl) 1983-07-01
DK158443B (da) 1990-05-21
FI811948L (fi) 1981-12-24
NZ197414A (en) 1984-10-19
NO812090L (no) 1981-12-28
FI75490C (fi) 1988-07-11
NL8102943A (nl) 1982-01-18
RO82720B (ro) 1984-07-30
IL63136A0 (en) 1981-09-13
IE51331B1 (en) 1986-12-10
AU541627B2 (en) 1985-01-17
AU7209781A (en) 1983-01-06
DE3124592A1 (de) 1982-02-11
KR840000693B1 (ko) 1984-05-21
IT1144812B (it) 1986-10-29
PT73239B (en) 1982-07-22
GB2078737B (en) 1984-03-14
DK158443C (da) 1990-10-08
AT380790B (de) 1986-07-10
NO156036B (no) 1987-04-06
ATA278881A (de) 1985-12-15
NL191777C (nl) 1996-08-02
HU183494B (en) 1984-05-28
IE811347L (en) 1981-12-23
BG37991A3 (en) 1985-09-16
FR2484835A1 (fr) 1981-12-24

Similar Documents

Publication Publication Date Title
GB2071683B (en) Pigment compositions
GB8520930D0 (en) Protection of substrate
JPS5781830A (en) Improvement of complex
GB2074156B (en) Preparation of n-octadienol
JPS57123112A (en) Effect increase of local composition
ZA814203B (en) Protection of lyophilized betalactams from color formation
NZ196228A (en) Preparation of 3-iodomethyl-cephalosporins
GB2068381B (en) Preparation of dialkyldithiophosphinates
GB2137222B (en) Preparation of meta-diisopropylbenzene
GB2078748B (en) Preparation of 2-methylenealdehydes
DE3165013D1 (en) Preparation of 2-hydroxytetrahydrofuran
ZA812789B (en) Preparation of mercapto-alcohols
JPS57179018A (en) Manufacture of blue ferrohexacyanophelate-iii pigment
JPS5794042A (en) Carbazolization of anthrimide
JPS56145237A (en) Isolation of monochloroacetaldehyde
NZ196539A (en) Preparation of n-substituted-2-haloacetanilides
IL60122A0 (en) Preparation of oxacycloalkenones
DE3161207D1 (en) Preparation of 2-imidazolines
JPS5751166A (en) Formation of inorganic matter
JPS56167010A (en) Protection of bridge cable
JPS5761131A (en) Porch hood
JPS5795951A (en) Manufacture of peptide
IL64470A0 (en) Preparation of trichlorothiazole
YU131080A (en) Protection of power-saws
GB2087377B (en) Preparation of 2-chlorobenzotrichloride